N-(4-Bromo-phen-yl)-2-[(1-cyclo-hexyl-meth-yl-1H-1,2,4-triazol-3-yl)sulfanyl]-acetamide

The title compound, C(17)H(21)BrN(4)OS, was synthesized as a potential reverse transcriptase (RT) inhibitor of the human immunodeficiency virus type 1 (HIV-1). In the molecule, there is an N-H⋯S hydrogen bond making a five-membered ring. In the crystal, mol-ecules are connected into centrosymmetric...

Full description

Saved in:
Bibliographic Details
Published inActa crystallographica. Section E, Structure reports online Vol. 68; no. Pt 5; p. o1495
Main Authors Wang, Yue-Ping, Yan, Wan-Lu, Guo, Qiong, He, Yan-Ping
Format Journal Article
LanguageEnglish
Published United States International Union of Crystallography 01.05.2012
Subjects
Organic Papers
Online AccessGet full text

Cover

More Information
Summary:The title compound, C(17)H(21)BrN(4)OS, was synthesized as a potential reverse transcriptase (RT) inhibitor of the human immunodeficiency virus type 1 (HIV-1). In the molecule, there is an N-H⋯S hydrogen bond making a five-membered ring. In the crystal, mol-ecules are connected into centrosymmetric dimers via pairs of N-H⋯N and weak C-H⋯N hydrogen bonds. The crystal structure also features C-H⋯O inter-actions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1600-5368
1600-5368
DOI:10.1107/S1600536812015991